13D Filing: Bay City Capital Fund V, L.P. and Sunesis Pharmaceuticals Inc (SNSS)

Page 13 of 13

Page 13 of 13 – SEC Filing


EXHIBIT INDEX

Exhibit 1 Joint Filing Agreement (incorporated by reference to Exhibit 7.1 to the Statement).
Exhibit 2 Form of Common Stock Purchase Warrant of the Issuer, issued to Bay City Capital Fund V, L.P. and Bay City Capital Fund V Co-Investment Fund, L.P. (incorporated by reference to Exhibit 4.2 the Issuers Current Report on Form
8-K, filed October 26, 2017).

Follow Viracta Therapeutics Inc. (NASDAQ:VIRX)

Page 13 of 13